JP2007519747A5 - - Google Patents

Download PDF

Info

Publication number
JP2007519747A5
JP2007519747A5 JP2006551554A JP2006551554A JP2007519747A5 JP 2007519747 A5 JP2007519747 A5 JP 2007519747A5 JP 2006551554 A JP2006551554 A JP 2006551554A JP 2006551554 A JP2006551554 A JP 2006551554A JP 2007519747 A5 JP2007519747 A5 JP 2007519747A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
piperacillin
pharmaceutically acceptable
tazobactam
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006551554A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007519747A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/003048 external-priority patent/WO2005074925A1/en
Publication of JP2007519747A publication Critical patent/JP2007519747A/ja
Publication of JP2007519747A5 publication Critical patent/JP2007519747A5/ja
Withdrawn legal-status Critical Current

Links

JP2006551554A 2004-01-30 2005-01-27 ピペラシリンおよびタゾバクタムを含みガラクトマンナンを実質的には含まない組成物 Withdrawn JP2007519747A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54091004P 2004-01-30 2004-01-30
PCT/US2005/003048 WO2005074925A1 (en) 2004-01-30 2005-01-27 Compositions substantially free of galactomannan containing piperacillin and tazobactam

Publications (2)

Publication Number Publication Date
JP2007519747A JP2007519747A (ja) 2007-07-19
JP2007519747A5 true JP2007519747A5 (cg-RX-API-DMAC10.html) 2008-03-13

Family

ID=34837439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551554A Withdrawn JP2007519747A (ja) 2004-01-30 2005-01-27 ピペラシリンおよびタゾバクタムを含みガラクトマンナンを実質的には含まない組成物

Country Status (7)

Country Link
US (1) US20050171077A1 (cg-RX-API-DMAC10.html)
EP (1) EP1711178A1 (cg-RX-API-DMAC10.html)
JP (1) JP2007519747A (cg-RX-API-DMAC10.html)
KR (1) KR20060127931A (cg-RX-API-DMAC10.html)
CN (1) CN1913890A (cg-RX-API-DMAC10.html)
CA (1) CA2553038A1 (cg-RX-API-DMAC10.html)
WO (1) WO2005074925A1 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1787641A1 (de) * 2005-11-22 2007-05-23 Helm AG Tazobactam-Piperacillin-Lyophilisat
ATE485043T1 (de) * 2005-12-05 2010-11-15 Sandoz Ag Verfahren zur herstellung von lyophilisiertem piperacillin-natrium in kombination mit tazobactam-natrium, mit verbesserter stabilität nach der rekonstitution
ITMI20070568A1 (it) * 2007-03-22 2008-09-23 Acs Dobfar Spa Comosizione farmaceutica sterile iniettabile avente piperacillina sodica e tazobactam sodico come principi attivi
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CN103006676B (zh) * 2012-12-27 2015-02-25 石药集团中诺药业(石家庄)有限公司 新型哌拉西林他唑巴坦组合物
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN113209030B (zh) * 2021-04-27 2023-04-25 海南通用康力制药有限公司 哌拉西林钠他唑巴坦钠无菌粉针剂的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4534977A (en) * 1981-03-26 1985-08-13 American Cyanamid Company Composition of matter comprising a low bulk density lyophilized preparation of Sodium Piperacillin
US4477452A (en) * 1981-03-26 1984-10-16 American Cyanamid Company Composition of matter comprising a lyophilized preparation of a penicillin derivative
US4562073A (en) * 1982-12-24 1985-12-31 Taiho Pharmaceutical Company Limited Penicillin derivatives
AUPQ137699A0 (en) * 1999-07-02 1999-07-22 University Of New England, The Control of acidosis
US6900184B2 (en) * 2003-04-14 2005-05-31 Wyeth Holdings Corporation Compositions containing pipercillin and tazobactam useful for injection
AU2003230899A1 (en) * 2003-04-14 2004-11-26 Wyeth Holdings Corporation Compositions containing piperacillin and tazobactam useful for injection

Similar Documents

Publication Publication Date Title
Susa et al. Comparative studies of different preservation methods and relative freeze-drying formulations for extracellular vesicle pharmaceutical applications
JP2019526628A5 (cg-RX-API-DMAC10.html)
CN101361713B (zh) 姜黄素纳米结晶制剂的制备方法
JP2012503489A5 (cg-RX-API-DMAC10.html)
JP2008509924A5 (cg-RX-API-DMAC10.html)
JP2019519570A5 (cg-RX-API-DMAC10.html)
JP2013523677A5 (cg-RX-API-DMAC10.html)
CN102863519B (zh) 一种盐酸万古霉素的精制方法
CN106146679B (zh) 一种纯化细菌荚膜多糖的方法
RU2014151424A (ru) Термостабильные составы вакцины
JPH02172922A (ja) 抗エイズウィルス剤
CN106497791B (zh) 一种金黄色葡萄球菌冻干制备用新型复合保护剂
JP2016528233A5 (cg-RX-API-DMAC10.html)
JP4319835B2 (ja) セフチオフルナトリウム塩の製造方法
CN101433519B (zh) 阿奇霉素滴眼剂及其制备方法
CN102803299A (zh) 透明质酸的提纯方法以及制造方法
CN1311815C (zh) 亚微米蜂胶微胶囊的制备方法
US20150141630A1 (en) Process for preparation of iron sucrose
RU2010135753A (ru) Способ ультраочистки альгинатов
CN111803650B (zh) 酪胺-岩藻聚糖在预防病毒经黏膜传播中的应用及其制备方法、药剂
CN104740599A (zh) 一种家蝇复合抗菌肽制剂
JP2013533304A5 (cg-RX-API-DMAC10.html)
CN103044509B (zh) γ-胞嘧啶核苷-5’-三磷酸二钠结晶化合物、其制备方法及其药物组合物
KR20230142752A (ko) 흡입을 위한 퓨린 억제제의 제제
JP5548838B2 (ja) バンコマイシン湿体の精製方法